zuclopenthixol

Small moleculeexperimental

Clinical trial activity

5 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
3

Earliest trial started Jan 1, 1998 (NCT00206960)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

OCCN1CCN(CC/C=C2\c3ccccc3Sc3ccc(Cl)cc32)CC1
Mol. weight
400.98 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cis-clopenthixol
  • cis-clopenthixol
  • cisordinol
  • clopixol
  • (z)-clopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol
  • zuclopenthixol dihydrochloride
  • zuclopenthixole
  • zuclopenthixole
  • zuclopenthixol hcl
  • zuclopenthixol hydrochloride
  • zuclopenthixolum
  • zuclopenthixolum
  • zuclopentixol
  • zuclopentixol

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02435095Phase 4May 1, 2015RWTH Aachen University
NCT02374567Phase 3Jan 1, 2015Gottfried Wilhelm Leibniz Universität Hannover
NCT02307396Phase 4Nov 1, 2014Technical University of Munich
NCT00767715Phase 4Oct 1, 2004Eli Lilly
NCT00206960N/AJan 1, 1998Government of Denmark, Johnson and Johnson, Novo Nordisk, University of Copenhagen
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eli LillyFor profit1112004
Gottfried Wilhelm Leibniz Universität HannoverAcademic/Hospital1112015
Government of DenmarkGovernment1011998
Johnson and JohnsonFor profit1011998
Novo NordiskFor profit1011998
RWTH Aachen UniversityAcademic/Hospital1112015
Technical University of MunichAcademic/Hospital1112014
University of CopenhagenAcademic/Hospital1111998
8 organizations
Page 1 / 1